COMPANIES | AQUAFEED

BioMar debuts on the Copenhagen Stock Exchange with Schouw & Co. retaining control

Copenhagen, 28 May 2026 | BioMar Group enters the public market at a time when aquaculture is seeking to scale production, reduce environmental impacts and attract long-term capital

BIOMAR NASDAQ Copenhaguen

BioMar Group A/S began trading this Thursday on the main market of Nasdaq Copenhagen after successfully completing its initial public offering (IPO), in a deal valuing the company at DDK 10.85 billion, equivalent around EUR 1.45 billion.

The stock market debut marks a significant milestone for the aquaculture nutrition company, giving greater financial visibility to one of the world’s leading producers of feed for fish and shrimp.

The offering was priced at DKK 108 per share and attracted strong demand from both institutional and retail investors.

According to the company, the transaction brought in more than 10,800 new stakeholders and resulted in an initial free float of between 25% and 29%, depending on the exercise of the over-allotment option. The total value of the offering amounts ot DDK 2.7 billion, rising to as much as DDK 3.1 billion if the option is exercised in full.

The main selling shareholder is Danish industrial holding company Schouw & Co., which has owned BioMar since 2005 and will continue to retain a majority controlling stake following the IPO. The transaction primarily consists of the sale of existing shares combined with a limited issuance of new shares worth DDK 50 million.

The shares are initially trading under the temporary symbol BIOMAR TEMP until the completion and settlement of the offering. Ordinary shares are expected to being trading under the ticker BIOMAR on 2 June 2026.

The stock market debut comes at a time of growing investor interest in aquaculture and, in particular, in strategic suppliers across the value chain.

BioMar operates in more than 90 countries and has an international industrial network focused on supplying nutritional solutions for species including salmon, trout, gilthead seabream, European seabass, shrimp and other farmed aquatic species.

Beyond the financial transaction itself, BioMar’s listing introduces a new public benchmark for assessing the economic relevance of aquaculture nutrition within the global food system.

It also allows greater transparency in tracking margins, investments, ingredient innovation, sustainability performance and international expansion at one of the sector’s leading companies.